Loading clinical trials...
Loading clinical trials...
Transvenous Approach for the Treatment of Cerebral Arteriovenous Malformations (TATAM): A Randomized Controlled Trial and Registry
A new endovascular route for the treatment of brain AVMs may be possible in some cases: Trans-Venous Embolization (TVE). The technique uses microcatheters to navigate to the draining veins of AVM, to reach and then fill the AVM nidus retrogradely with liquid embolic agents until the lesion is occluded. This technique has the potential to improve on some of the problems with the arterial approach to AVM embolization, such as a low overall occlusion rate. However, by occluding the vein first, and filling the lesion with the embolic agent in a retrograde fashion, the method transgresses a widely held dogma in the surgical or endovascular treatment of AVMs: to preserve the draining vein until all afferent vessels have been occluded. Nevertheless, the initial case series have shown promising results, with high occlusion rates, and few technical complications. The method is increasingly used in an increasing number of centers, but there is currently no research protocol to guide the use of this promising but still experimental treatment in a prudent fashion. Care trials can be designed to offer such an experimental treatment, taking into account the best medical interests of patients, in the presence of rapidly evolving indications and techniques.
Age
All ages
Sex
ALL
Healthy Volunteers
No
University of Alberta Hospital
Edmonton, Alberta, Canada
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
Centre hospitalier universitaire de Bordeaux
Bordeaux, France
Centre hospitalier régional universitaire de Brest
Brest, France
Centre hospitalier universitaire de Grenoble
Grenoble, France
Centre hospitalier universitaire Limoges
Limoges, France
Hôpital Forndation Adolphe de Rothschild
Paris, France
Centre hospitalier universitaire de Rouen Normandie
Rouen, France
Centre hospitalier universitaire de la Réunion
Saint-Paul, France
Start Date
August 2, 2018
Primary Completion Date
January 24, 2025
Completion Date
July 23, 2025
Last Updated
July 28, 2025
77
ACTUAL participants
Standard Trans-Arterial Embolization (TAE)
PROCEDURE
Trans-Venous Embolization (TVE)
PROCEDURE
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions